Skip Navigation
Skip to contents

JKSCT : Journal of The Korean Society of Clinical Toxicology

OPEN ACCESS
SEARCH
Search

Articles

Page Path
HOME > J Korean Soc Clin Toxicol > Volume 18(2); 2020 > Article
Assessment and Methods of Nutritional Support during Atropinization in Organophosphate and Carbamate Poisoning Cases
Jong-uk Park, Young-gi Min, Sangcheon Choi, Dong-wan Ko, Eun Jung Park
Journal of The Korean Society of Clinical Toxicology 2020;18(2):123-129
DOI: https://doi.org/10.22537/jksct.2020.18.2.123
Published online: December 31, 2020
  • 261 Views
  • 4 Download
  • 1 Crossref
  • 0 Scopus
1Department of Emergency Medicine, Ajou University School of Medicine
2Department of Emergency Medicine, Ajou University School of Medicine
3Department of Emergency Medicine, Ajou University School of Medicine
4Department of Emergency Medicine, Ajou University School of Medicine
5Department of Emergency Medicine, Ajou University School of Medicine

Purpose: Atropine is an antidote used to relieve muscarinic symptoms in patients with organophosphate and carbamate poisoning. Nutritional support via the enteral nutrition (EN) route might be associated with improved clinical outcomes in critically ill patients. This study examined the administration of nutritional support in patients undergoing atropinization, including methods of supply, outcomes, and complications. Methods: A retrospective observational study was conducted in a tertiary care teaching hospital from 2010 to 2018. Forty-five patients, who were administered with atropine and on mechanical ventilation (MV) due to organophosphate or carbamate poisoning, were enrolled. Results: Nutritional support was initiated on the third day of hospitalization. Thirty-three patients (73.3%) were initially supported using parenteral nutrition (PN). During atropinization, 32 patients (71.1%) received nutritional support via EN (9) or PN (23). There was no obvious reason for not starting EN during atropinization (61.1%). Pneumonia was observed in both patient groups on EN and PN (p=0.049). Patients without nutritional support had a shorter MV duration (p=0.034) than patients with nutritional support. The methods of nutritional support during atropinization did not show differences in the number of hospital days (p=0.711), MV duration (p=0.933), duration of ICU stay (p=0.850), or recovery at discharge (p=0.197). Conclusion: Most patients undergoing atropinization were administered PN without obvious reasons to preclude EN. Nutritional support was not correlated with the treatment outcomes or pneumonia. From these results, it might be possible to choose EN in patients undergoing atropinization, but further studies will be necessary.

Related articles

JKSCT : Journal of The Korean Society of Clinical Toxicology